) was observed to be associated with mitigation of these effects. Together, these findings are consistent with a proposed adverse outcome pathway (AOP) framework that suggests a link between the EtCBN-Irf7 interaction and LCM-associated neurotoxicity, offering potential mechanistic insights and therapeutic targets for olfactory dysfunction.
Duan et al. (Tue,) studied this question.